Primary Record
Linsitinib
Note: Only for scientific research or as raw materials for production.
- In stock
- 892 g
- Purity
- 98.1 %
- CAS
- 867160-71-2
Compound Identifiers & Properties
- CAS
- 867160-71-2
- PubChem CID
- 11640390
- SMILES
- CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O
- Canonical SMILES
- CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1
Names & Synonyms
- Linsitinib
- OSI-906
- 867160-71-2
- OSI-906 (Linsitinib)
- Linsitinib(OSI-906)
- Linsitinib [USAN]
- OSI906
- OSI 906
- OSI-906AA
- Kinome_3532
- Linsitinib [USAN:INN]
- OSI906/Linsitinib/
- Linsitinib; OSI-906
- ASP-7487
- LINSITINIB [INN]
- Linsitinib (USAN/INN)
- RefChem:928309
- UNII-15A52GPT8T
- Linsitinib (OSI-906)
- Linsitinib(OSI-906)?
- D01GFX
- C26H23N5O
- 15A52GPT8T
- LINSITINIB [WHO-DD]
- MFCD12912153
- CHEMBL1091644
- cc-217
- MLS006010304
- SCHEMBL400369
- SCHEMBL400734
- SCHEMBL400735
- GTPL7423
- orb1301148
- CHEMBL1996234
- SCHEMBL10255925
- SCHEMBL29392484
- CHEBI:91402
- EX-A719
- QCR-128
- MMV676605
- BCPP000137
- BDBM185150
- DTXSID401007055
- DTXSID901121553
- GLXC-90207
- HMS3295G15
- HMS3654C19
- AOB87170
- BCP01831
- KS-00000T7A
- ABP000779
- BDBM50315887
- C26-H23-N5-O
- NSC756652
- NSC800784
- s1091
- ZINC53239527
- AKOS024464740
- ZINC100071817
- ZINC113742575
- BCP9001035
- CCG-264815
- CS-0242
- DB06075
- EBC-221067
- FO65116
- NSC-756652
- NSC-800784
- PB22643
- RL05373
- SDCCGSBI-0646932.P001
- CID11640390
- NCGC00250375-02
- NCGC00250375-03
- NCGC00250375-11
- NCGC00250375-14
- AC-26953
- AK176016
- AS-16999
- BC638839
- CID 11640390
- HY-10191
- SC-95136
- SMR004700744
- 3-[8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutan-1-ol
- A8334
- FT-0670821
- NS00073285
- SW218150-2
- X7473
- J3.288.961A
- A11053
- D09925
- W-5542
- SR-05000022538
- Q6554803
- SR-05000022538-1
- BRD-K07667918-001-01-3
- BRD-K86118762-001-01-8
- BRD-K86118762-001-05-9
- OSI-906, 867160-71-2
- Q27163260
- Cis-3-(8-Amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutan-1-ol
- cis-3-(8-amino-1-(2-phenyl-7-quinolinyl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol
- cis-3-[8-Amino-1-(2-phenyl-7-quinolinyl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutanol
- (1r,3r)-3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutanol.
- (1s,3r)-3-[8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutan-1-ol
- (1s,3s)-3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutan-1-ol
- 3-[8-amino-1-(2-phenyl-7-quinolinyl)-3-imidazo[1,5-a]pyrazinyl]-1-methyl-1-cyclobutanol
- 3-[8-amino-1-(2-phenyl-7-quinolyl)imidazo[1,5-a]pyrazin-3-yl]-1-methyl-cyclobutanol
- cis-3-(8-Amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutanol
- cis-3-[8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutanol
- (1r,3r)-3-[8-Amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutan-1-ol
- (1R,3S)-3-[8-AMINO-1-(2-PHENYLQUINOLIN-7-YL)IMIDAZO[1,5-A]PYRAZIN-3-YL]-1-METHYLCYCLOBUTAN-1-OL
- (1s,3s)-3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutanol
- (1s,3s)-3-[8-Amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutan-1-ol
- 1356958-77-4
- 3-(8-amino-1-(2-phenylquinolin-7-yl)-2,3-dihydroimidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutanol
- 3-[8-AMINO-1-(2-PHENYL-QUINOLIN-7-YL)-IMIDAZO[1,5-A]PYRAZIN-3-YL]-1-METHYL-CYCLOBUTANOL
- 3alpha-[8-Amino-1-(2-phenylquinoline-7-yl)imidazo[1,5-a]pyrazine-3-yl]-1-methylcyclobutane-1alpha-ol
- 867160-72-3
- CIS-3-(8-AMINO-1-(2-PHENYLQUINOLIN-7-YL)IMIDAZO(1,5-A)PYRAZIN-3-YL)-1-METHYLCYCLOBUTAN-1-OL
- cis-3-[8-Amino-1-(2-phenyl-7-quinolinyl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutanol; OSI 906; OSI 906AA;
- CYCLOBUTANOL, 3-(8-AMINO-1-(2-PHENYL-7-QUINOLINYL)IMIDAZO(1,5-A)PYRAZIN-3-YL)-1-METHYL-, CIS-
- trans-3-[8-Amino-1-(2-phenyl-7-quinolinyl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutanol